646PFIRST STAGE ANALYSIS OF IRINOTECAN, CAPECITABINE (XELODA®), AND OXALIPLATIN (IXO) AS FIRST-LINE TREATMENT OF HER2- METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Spratlin, J., Mulder, K., Brezden-Masley, C., Vickers, M.M., Kennecke, H., Fields, A.L.A., Au, H., Maroun, J.A.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu334.31
Date:
September, 2014
File:
PDF, 61 KB
2014